KLOW (GHK-Cu / BPC-157 / TB-500 / KPV) (80 (50/10/10/10))
$179.00
A proprietary four-compound research blend combining GHK-Cu, BPC-157, TB-500, and KPV, formulated for laboratory investigation of tissue biology, anti-inflammatory signaling, and extracellular matrix pathways.
Buy 1
SAVE 0%
Buy 3
SAVE 20%
Buy 5
SAVE 33%
Buy 7+
SAVE 50%
Description
KLOW is a proprietary research blend developed by AURAˣˣ and ALPHAˣʸ, expanding the GLOW formulation with the addition of KPV (10mg), the C-terminal tripeptide fragment of alpha-MSH studied for its anti-inflammatory and immunomodulatory interactions with melanocortin receptors. Combined with GHK-Cu (50mg), BPC-157 (10mg), and TB-500 (10mg), this four-compound formulation is designed for laboratory research exploring the intersection of tissue repair signaling, extracellular matrix biology, cytoskeletal regulation, and inflammatory pathway modulation.
The inclusion of KPV adds a melanocortin receptor-mediated anti-inflammatory dimension to the established tissue biology research profile of the GLOW formulation, providing researchers with a more comprehensive multi-pathway investigative tool. All four components are individually characterized in published preclinical literature, supporting rigorous independent and combined laboratory investigation.
Supplied as a precision-blended Research Use Only (RUO) material, analytically verified for the identity and purity of all four components, with batch-specific Certificate of Analysis documentation.
